MEI Pharma Inc Zandelisib Program Update Webcast Transcript
Good day, and welcome to the MEI Pharma Zandelisib Program Update Webcast. (Operator Instructions) Please note, today's event is being recorded.
I would now like to turn the conference over to David Walsey, Senior Vice President, Corporate Affairs at MEI Pharma. Please go ahead, sir.
Thank you, and thanks, everyone, for joining our webcast today.
Before we get started, I want to call your attention to the fact that this conference call may contain certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in our forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties as discussed in our SEC filings, including our most recent annual report on Form 10-K filed for the period ending June 30, 2021, and our quarterly reports on Form 10-Q
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
